Cerebral blood flow velocity after surfactant instillation in preterm infants
- PMID: 1993962
- DOI: 10.1016/s0022-3476(05)80503-7
Cerebral blood flow velocity after surfactant instillation in preterm infants
Similar articles
-
[Cerebral blood flow velocity after surfactant instillation in preterm infants].Pediatr Med Chir. 1991 Jul-Aug;13(4):439-40. Pediatr Med Chir. 1991. PMID: 1754482 Italian. No abstract available.
-
Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome.Am J Perinatol. 1994 Nov;11(6):382-5. doi: 10.1055/s-2007-994602. Am J Perinatol. 1994. PMID: 7857426
-
Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.J Pediatr. 1993 Mar;122(3):446-52. doi: 10.1016/s0022-3476(05)83439-0. J Pediatr. 1993. PMID: 8441104 Clinical Trial.
-
Surfactant and respiratory distress syndrome.Turk J Pediatr. 1996 Jan-Mar;38(1):37-43. Turk J Pediatr. 1996. PMID: 8819619 Review.
-
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.Drugs. 1991 Nov;42(5):877-94. doi: 10.2165/00003495-199142050-00009. Drugs. 1991. PMID: 1723378 Review.
Cited by
-
Surfactant replacement therapy.Thorax. 1996 Nov;51(11):1137-54. doi: 10.1136/thx.51.11.1137. Thorax. 1996. PMID: 8958900 Free PMC article. Review. No abstract available.
-
Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.Arch Dis Child Fetal Neonatal Ed. 1994 Nov;71(3):F174-8. doi: 10.1136/fn.71.3.f174. Arch Dis Child Fetal Neonatal Ed. 1994. PMID: 7820712 Free PMC article. Clinical Trial.
-
Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.J Natl Med Assoc. 1994 Jan;86(1):46-52. J Natl Med Assoc. 1994. PMID: 8151722 Free PMC article. Clinical Trial.
-
Surfactant replacement therapy: a new risk factor in developing retinopathy of prematurity?Eur J Pediatr. 1994 Feb;153(2):113-6. doi: 10.1007/BF01959221. Eur J Pediatr. 1994. PMID: 8157017
-
A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.Drug Saf. 1998 May;18(5):321-37. doi: 10.2165/00002018-199818050-00002. Drug Saf. 1998. PMID: 9589844
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources